248 related articles for article (PubMed ID: 9658179)
1. Osteoblastic responses to TGF-beta during bone remodeling.
Erlebacher A; Filvaroff EH; Ye JQ; Derynck R
Mol Biol Cell; 1998 Jul; 9(7):1903-18. PubMed ID: 9658179
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
Filvaroff E; Erlebacher A; Ye J; Gitelman SE; Lotz J; Heillman M; Derynck R
Development; 1999 Oct; 126(19):4267-79. PubMed ID: 10477295
[TBL] [Abstract][Full Text] [Related]
3. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher A; Derynck R
J Cell Biol; 1996 Jan; 132(1-2):195-210. PubMed ID: 8567723
[TBL] [Abstract][Full Text] [Related]
5. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
6. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.
Weivoda MM; Ruan M; Pederson L; Hachfeld C; Davey RA; Zajac JD; Westendorf JJ; Khosla S; Oursler MJ
J Bone Miner Res; 2016 Jan; 31(1):76-85. PubMed ID: 26108893
[TBL] [Abstract][Full Text] [Related]
9. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of bone resorption by osteocytes].
Nakashima T; Hayash M; Takayanagi H
Clin Calcium; 2012 May; 22(5):685-96. PubMed ID: 22549193
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.
Ota K; Quint P; Weivoda MM; Ruan M; Pederson L; Westendorf JJ; Khosla S; Oursler MJ
Bone; 2013 Nov; 57(1):68-75. PubMed ID: 23891907
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts.
Zeng HC; Bae Y; Dawson BC; Chen Y; Bertin T; Munivez E; Campeau PM; Tao J; Chen R; Lee BH
Nat Commun; 2017 Apr; 8():15000. PubMed ID: 28397831
[TBL] [Abstract][Full Text] [Related]
13. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
14. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P
Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
16. TSH is a negative regulator of skeletal remodeling.
Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
Plotkin LI; Lezcano V; Thostenson J; Weinstein RS; Manolagas SC; Bellido T
J Bone Miner Res; 2008 Nov; 23(11):1712-21. PubMed ID: 18597631
[TBL] [Abstract][Full Text] [Related]
18. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
[TBL] [Abstract][Full Text] [Related]
19. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]